Aurobindo Pharma bets on low-cost strengths

16108 Investors following Aurobindo Pharm. Share this News with them.

0

Like this story, share it with millions of investors on M3

Aurobindo Pharma bets on low-cost strengths

Aurobindo Pharma Ltd (APL) one of the lowest cost manufacturers of pharma products in the world, plans to use this advantage to consolidate its presence in both the domestic market and regulated markets such as US, Europe and Japan.

Post your opinion here

 

0

Tweet

Share on Tumblr

RELATED NEWS Aurobindo receives approval in Citalopram oral solution Aurobindo’s expertise excels in packaging too Aurobindo gets S African nod for Betelactam unit ALSO READ See latest News about Aurobindo Pharm See previous management interviews See what other Experts & Brokerages are saying about Aurobindo Pharm Aurobindo Pharm BSE | NSE 25/05/12 Are Mutual Funds betting on Aurobindo Pharm?

Aurobindo Pharma Ltd (APL) one of the lowest cost manufacturers of pharma products in the world, plans to use this advantage to consolidate its presence in both the domestic market and regulated markets such as US, Europe and Japan.

According to the APL Chairman, Mr P.V. Ramaprasad Reddy, markets, the world over, were turning sensitive to increasing cost of drugs and Governments, insurance companies and consumers were seeking to reduce their medical bills.

"While high cost research and development continues to be made by all large players, it has become essential to find ways and means to reduce the cost at the point of delivery.

A balance needs to be found between innovation and effective cure on the one side, and affordable drug pricing on the other," Mr Reddy said, while addressing the shareholders at the 19th annual general meeting (AGM) here.

Contd on Pg 2...